GE Healthcare has launched an ‘off-the-shelf’ range of modular biomanufacturing facilities that it claims can be designed, constructed and operational in under two years.
Repligen should consider selling its bioprocessing unit, which sells materials used in mAb production, to make best use of its assets, a shareholder suggests.
Spectrum Pharmaceuticals and Viropro are to develop a biosimilar version of rituximab, a monoclonal antibody cancer treatment sold by Roche and Biogen Idec.
CMO Avid Bioservices’ revenues rose by 74 per cent to $2.1m (€1.5m) in Q2, generating a further $7m from its parent company, and it has plans to boost output and become a leader in mammalian cell culture production.
Swiss life sciences solutions firm Lonza has been contracted by US biotechnology group Elusys Therapeutics to produce Anthim, its late stage Ab candidate treatment for anthrax infection.
CIT is launching a tissue cross-reactivity service, which will allow biotechs to screen monoclonal antibody-based therapies for tissue binding, in response to rising market demand.
An increase in the sale of vaccines such as Quinvaxem and Epaxal, helped Dutch drugmaker Crucell reduce its loss some 56 per cent to €7.9m ($12.5m) in the second quarter.
Industrial separation specialist Upfront Chromatography believes
that its new range of disposable absorption chromatography units
will help monoclonal antibody (MAb) makers significantly reduce
production costs.
Dutch biotech Crucell and its US partner DSM Biologics have
achieved a record yield of 15 grams per litre with their PER.C6
cell line technology for the production of monoclonal antibodies
and recombinant proteins.
Furious trading in shares of PDL BioPharma has taken place over the
past couple of days as investors jumped in with both pockets open
in the hope that a partner will soon be in the offing for the
ailing firm.
Australia is soon to boast the largest monoclonal antibody
production facility in the Southern Hemisphere, which will go some
way in alleviating the increasing demand for the biologic agents.
Germany's Merck has announced its biggest investment in
pharmaceuticals in its 338-year-old history, as its top-selling
oncology drug Erbitux (cetuximab) has driven the company to
allocate €190m for the construction of its first...
Momentum is growing at the UK's new National Biomanufacturing
Centre (NBC) as its operator Eden Biodesign inked a second contract
at the centre - set up to establish England's Northwest as one of
the top biomanufacturing...
The drug trial catastrophe, which has endangered the lives of six
male volunteers of which two are still in a coma, could've been
avoided after a similar study conducted last year yielded similar
side effects.
Chromos has announced an expansion to an existing Pfizer
collaboration, which builds on research focusing on genetic
engineering of production cell lines with multiple genes to improve
bioreactor performance and reduce monoclonal...
Roche has formed a research collaboration with Epitomics, giving
Roche a license to Epitomics' monoclonal antibody technology
(RabMab technology) for the discovery and development of monoclonal
antibodies to treat cancer and...
US biotechnology major Genzyme officially opened four European
facilities last week as part of a investment package eventually
expected to cost $540 million (€449m).
The worldwide market for therapeutic and diagnostic monoclonal
antibodies is expected to reach $26 million (€21.2 million) by
2010, buoyed on by technological advances that allow antibodies to
exhibit a specified targeted attack on...
MedImmune has announced Phase I clinical trial results of an
antibody that appeared to be safe and well tolerated in patients
with certain T-cell lymphomas and leukemias. The results signify
the emergence of monoclonal antibodies...
According to a new report the therapeutic antibody market is
expected to treble in size by 2010 as significant leaps forward
coupled with safer and more effective humanised and fully human
antibodies are pouring onto the market fulfilling...
Morphotek has announced the Food and Drug Administration (FDA) has
accepted its New Drug Application for a humanised monoclonal
antibody, intended for the treatment of advanced ovarian cancer.
GE Healthcare has launched two new products designed to meet
growing industry needs for the purification of monoclonal
antibodies, one of the fastest growing drug classes in the drug
industry.
GE Healthcare announced the launch of two new purification tools
designed to meet growing industry needs for the advancement of
monoclonal antibody (MAbs) research and development. The tools
become the latest offering in the chromatography...
Integra Biosciences has launched the CELLine disposable flask,
which harnesses membrane technology that is suitable for
recombinant protein expression and high yield monoclonal antibody
production.
The European monoclonal antibody therapeutics market is set to grow
at a compound annual growth rate (CAGR) of 34.1 per cent to $11.4
billion (€8.7 billion) by 2011. The growth is fuelled by the need
for safe and effective treatment...
GPC Biotech announced the initiation of a Phase I trial with its
anticancer monoclonal antibody, 1D09C3, which has already proved
effective in the treatment of lymphoid tumours including
non-Hodgkin's lymphoma.
German biotechnology company MorphoSys' acquisition of two
Biogenesis antibody technology companies elevates it to one of the
largest European suppliers of antibodies to the life sciences
research community.
Tepnel announced it had completed the acquistion of Diaclone
Research adding customisable monoclonal antibodies (mABs),
complimentary reagents and ELISA test kits to its range of life
sciences instrumentation and services.
Astrazeneca and Cambridge Antibody Technology (CAT) have entered
into an alliance to jointly discover and develop human monoclonal
antibody therapeutics, principally in the field of inflammatory
disorders, including respiratory diseases....
The European Commission has launched an €11.4 million project to
identify ways of improving the production of biologic drugs and
cutting the cost of treatment.
The European Molecular Biology Laboratory (EMBL) has joined forces
with a Taiwanese company Abnova, to develop a high-throughput
system for making monoclonal antibodies (MAbs).
According to a latest report, the growth of the biotechnology
company will continue to outpace that of pharmaceutical companies,
with the seven largest biotechnology companies growing at rates
faster than the pharmaceutical industry's...
Life sciences company Tepnel has signed a conditional agreement to
acquire OpiSAS' (Opi) subsidiary Diaclone Research, a company that
produces monoclonal antibodies for in vitro studies and
diagnostic purposes.
US biopharmaceutical firm Acceptys has licensed an immortal
humanised cell line from Columbia University, which will allow it
to discover and produce fully human monoclonal antibodies and other
human proteins for use as therapeutic...
